Compare Halozyme Therapeutics Inc. Common Stock (HALO) vs Southern Company (SO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Halozyme Therapeutics Inc. Common Stock vs Southern Company — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $109.67 (market cap $12.58B), while Southern Company trades at $86.29 (market cap $98.29B). The key difference: Southern Company is far larger — about 7.8× Halozyme Therapeutics Inc. Common Stock's market cap, and Southern Company pays a 3.56% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 0 Days and Southern Company for 12 Days on average.
| HALO | SO | |
|---|---|---|
Market Cap | $12.58B | $98.29B |
Volume | 2,179,278 | 5,624,994 |
Sector | Health | Utilities |
52-Week High | $115.22 | $99.72 |
52-Week Low | $61.63 | $82.35 |
Typical Hold Time | 0 Days | 12 Days |
Enterprise Value | $14.49B | $172.39B |
Dividend Yield | — | 3.56% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →About Southern Company
Southern Company is a U.S. energy company with electric and gas utility businesses. Its power generation portfolio includes natural gas, nuclear, renewable, and other energy sources.
Read more on SO →
